Matching articles for "October 8"
Issue 1271 · October 8, 2007
Influenza Vaccine 2007-2008

Annual immunization against influenza A and B is the most effective method of preventing infection and has been shown to reduce associated complications.

Med Lett Drugs Ther. 2007 Oct 8; 49(1271):81-3
Annual immunization against influenza A and B is the most effective method of preventing infection and has been shown to reduce associated complications.
Issue 1271 · October 8, 2007
Blood Test for Tuberculosis

Quantiferon - TB Gold (Cellestis) is a T-cell interferon-gamma release assay approved by the FDA as an alternative to the tuberculin skin test for diagnosis of infection with Mycobacterium tuberculosis (TB).…

Med Lett Drugs Ther. 2007 Oct 8; 49(1271):83-4
Quantiferon - TB Gold (Cellestis) is a T-cell interferon-gamma release assay approved by the FDA as an alternative to the tuberculin skin test for diagnosis of infection with Mycobacterium tuberculosis (TB). An earlier assay (Quantiferon-TB) , which is no longer commercially available, was approved by the FDA in 2001. Other interferon-gamma release assays (IGRAs) are available abroad.
Issue 1271 · October 8, 2007
Addendum: Sunscreens and DEET

An article ( Med Lett Drugs Ther 2007; 49:41 ) on sunscreens in the May 21 issue of The Medical Letter included a statement that if sunscreens and the insect repellent DEET are used together, DEET should be…

Med Lett Drugs Ther. 2007 Oct 8; 49(1271):84
An article ( Med Lett Drugs Ther 2007; 49:41 ) on sunscreens in the May 21 issue of The Medical Letter included a statement that if sunscreens and the insect repellent DEET are used together, DEET should be applied first to avoid decreasing the effectiveness of the sunscreen. However, a recent in vitro study in human skin found that sunscreen increases absorption of DEET, especially when DEET is applied first (T Wang and X Gu. J Pharm Pharm Sci 2007; 10:17) . Whether this practice could cause clinical toxicity is unclear. Some travel experts recommend applying sunscreen first.
Issue 1271 · October 8, 2007 Free
Correction: Low Dose Transdermal Estrogens

The Medical Letter article ( Med Lett Drugs Ther 2007; 49:71 ) on Low-Dose Transdermal Estrogens said that Elestrin has been marketed in Europe since 1976. Actually it is EstroGel (Ascend Therapeutics), a…

Med Lett Drugs Ther. 2007 Oct 8; 49(1271):84
The Medical Letter article ( Med Lett Drugs Ther 2007; 49:71 ) on Low-Dose Transdermal Estrogens said that Elestrin has been marketed in Europe since 1976. Actually it is EstroGel (Ascend Therapeutics), a similar product, that has been available in Europe since 1976.